The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Charles Riv­er to ex­pand Ire­land man­u­fac­tur­ing site to add Covid-19 vac­cine ca­pac­i­ty

4 years ago
Coronavirus

Take­da dou­bles down at Cal­i­for­nia site as it looks to grow rare dis­ease man­u­fac­tur­ing base

4 years ago

Re­silience shells out $110M for blue­bird bio site, kick­start­ing new col­lab­o­ra­tion

4 years ago

Af­ter a months-long halt on pro­duc­tion, Emer­gent is back up and run­ning in Bal­ti­more

4 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Top diplo­mat calls for low-cost, over­seas pro­duc­tion of shots; Viet­nam inks deal for Japan­ese vac­cine tech trans­fer

4 years ago
Coronavirus

BioN­Tech is spear­head­ing an mR­NA vac­cine de­vel­op­ment pro­gram for malar­ia, with a tech trans­fer planned for Africa

4 years ago
R&D

Seat­tle's Lu­men will move in­to new head­quar­ters in for­mer long-lived bak­ery amid tri­al ex­pan­sion

4 years ago

US gov­ern­ment drops $200M in­to South African man­u­fac­tur­ing op­er­a­tion for Covid-19 vac­cines

4 years ago
Coronavirus

Re­ci­pharm to con­struct new In­di­an fill-fin­ish fa­cil­i­ty as part of ex­ist­ing re­la­tion­ship with Nichep­harm found­ing fam­i­ly'

4 years ago
Outsourcing

Covid-19 man­u­fac­tur­ing roundup: Mod­er­na inks deal for boost­er shots with Japan; Sput­nik Light could be man­u­fac­tured in Kaza­khstan — re­port

4 years ago
Coronavirus

As part of move­ment to boost African pres­ence, Gri­fols to build IV bag fa­cil­i­ty in Nige­ria

4 years ago

Catal­ent keeps adding on at key Ital­ian plant, this time with a pair of new biore­ac­tors and 100 jobs

4 years ago
Outsourcing

Pfiz­er and BioN­Tech team up with South African man­u­fac­tur­er, but it will on­ly han­dle fill-fin­ish

4 years ago
Coronavirus

In­dus­try groups warn of drug short­ages linked to wide­spread car­cino­gen test­ing as FDA dou­bles down on its ap­proach

4 years ago
FDA+

Flex­ing its new­found wealth, BioN­Tech snaps up a TCR plat­form and man­u­fac­tur­ing site as Gilead ex­its

4 years ago
Deals
Cell/Gene Tx

FDA sup­ports lim­it­ed dis­tri­b­u­tion of an­ti­smok­ing drug Chan­tix de­spite car­cino­gen risk

4 years ago
FDA+

CD­MO AM­RI re­brands and snags a pair of small­er com­pa­nies to aid its shift to be­come a glob­al brand name

4 years ago
R&D

Gen­er­a­tion Bio snaps up Boston area plant as it rolls out a man­u­fac­tur­ing process it thinks will be a game chang­er

4 years ago
R&D

Catal­ent lands 2 new part­ner­ships, in­clud­ing for glioblas­toma drug; US drops $153M in­to pan­dem­ic pre­pared­ness

4 years ago
Outsourcing

As its next big bet, Sana inks long-term lease for man­u­fac­tur­ing site for next-gen cell ther­a­pies

4 years ago
Cell/Gene Tx

Al­ready sit­ting on a ma­jor stem cell bank, Gen­er­ate looks to grow its re­gen­er­a­tive med­i­cines busi­ness

4 years ago
Outsourcing

Covid-19 man­u­fac­tur­ing roundup: FDA frees up more Emer­gent vac­cine dos­es; Pfiz­er and Viet­nam dis­cuss tech trans­fer — re­port

4 years ago
Coronavirus

A cou­ple months af­ter land­ing $100 mil­lion in fund­ing, Cel­lares grabs part­ner for its Cell Shut­tle

4 years ago
Outsourcing

Nkar­ta signs its name to an am­bi­tious fu­ture with man­u­fac­tur­ing hub for not one but mul­ti­ple mar­ket­ed drugs

4 years ago
Cell/Gene Tx
First page Previous page 67686970717273 Next page Last page
A service from the Financial Times